-
effectivehealthcare-admin.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
January 01, 2012 - #06 Developmental Delays ADHD, and Autism
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 06: Developmental Delays, ADHD, and
Autism
Potential High Impact Interventions Report
Prepared for:
Agency for Healthcare Research and Quality
U.S. D…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
August 01, 2012 - women (age 65 and older) who
were enrolled in Medicare fee-for-service
Parts A and B (entitlement indicator … of
“3” and HMO indicator of “0” or “4”)
for at least two months prior to diagno-
sis and four months … assistance for at least one month in 2007 using the State Reported Dual
Eligible Status Code monthly indicator
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
September 02, 2013 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
September 02, 2013 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - This group may be internal (i.e., a comparison group
within the study without the indicator(s) of disparity … external (i.e., data or statistics from a population with close geographic proximityb
but without the indicator … a
The selected measures of disparity will also be referred to as “disparity indicators” or “indicator
-
effectivehealthcare-admin.ahrq.gov/products/uterine-fibroids/research-protocol
May 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: April 06, 2010
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety of Oral Diabetes Medications for Adu…
-
effectivehealthcare-admin.ahrq.gov/products/stem-cell-children/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/major-depressive-disorder/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical
Antipsychotics – Update
I. Background and Objectives for the Sys…
-
effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-quality-meaures/research
January 01, 2020 - As chemotherapy-related adverse effects (i.e., toxicity) may also be a more specific indicator of overly … near the end-of-life than the use of chemotherapy more broadly, this is also a potentially important indicator … Chemotherapy toxicity may be an indicator that the risks of chemotherapy surpass the benefits. … In the prospective cohort, the prevalence of this indicator increased with the predicted probability
-
effectivehealthcare-admin.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - Evidence-based Practice Center Systematic Review Protocol
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST
Elevation Myocardial Infarction
Amendment Date(s):
Amendment 1 – December 11, 2012
(Amendment Detail…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
December 01, 2015 - 1
Comparative Effectiveness Review
Number 161
Nonpharmacological Versus Pharmacological
Treatments for Adult Patients With Major
Depressive Disorder
Executive Summary
Background
Major depressive disorder (MDD)1 is
the most prevalent and disabling form
of depression, affecting more than
16 percent of U.S…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - uterine-fibroids-protocol-160301
Source: www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Management of Uter ine Fibroids
I. Background and Objectives for the Systematic Review
Topic background
Most women will dev…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Procalcitonin as a Diagnostic Indicator to Initiate Early Therapy in Patients
with Suspected Infection … Procalcitonin as an Indicator of Response to Therapy
Population(s):
Source: www.effectivehealthcare.ahrq.gov … persistent or recurrent
infection, antibiotic
resistance)
Testing
G
H
Procalcitonin as Diagnostic Indicator … for Infection and
as an Indicator of Response to Therapy
Source: www.effectivehealthcare.ahrq.gov
-
effectivehealthcare-admin.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
January 01, 2024 - Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update
Comparative Effectiveness Review
Number 250
Living Systematic Review on Cannabis
and Other Plant-Based Treatments for
Chronic Pain: 2024 Update
Exec…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - The medication use indicator
variables were constructed so that if a patient filled a 30-day
prescription … for an oral hypoglycemic medication, the month
in which he or she filled it would have an indicator … If it was a 90-day supply, the patient
would have an indicator signifying that he or she had the
medication … An indicator variable was made to indicate whether during
the 2-month interval the patient was on (a)
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: January 10, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment
of Chronic Plaque Psoriasis …